Sitared 25MG Tab

Tablet

Treatment of type 2 diabetes mellitus to improve blood sugar control, as monotherapy or in combination with other antidiabetic medicines (along with diet and exercise).

Sitagliptin is a DPP-4 inhibitor that increases levels of incretin hormones (GLP-1 and GIP). This enhances glucose-dependent insulin release and reduces glucagon secretion, thereby lowering blood glucose levels with a low risk of hypoglycaemia when used alone.

Take orally exactly as prescribed, usually once daily, with or without food. Swallow tablet whole with water; take at the same time each day. Dose may need adjustment in kidney disease—do not change dose without doctor advice.

Headache, nasopharyngitis (common cold), upper respiratory tract infection, nausea, diarrhoea, stomach discomfort

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in kidney impairment; dose adjustment/monitoring of renal function is required. Rare but serious: pancreatitis (seek care for severe persistent abdominal pain), severe joint pain, hypersensitivity reactions (rash, swelling, breathing difficulty), bullous pemphigoid. Risk of hypoglycaemia increases when combined with insulin or sulfonylureas—may require dose reduction. Inform doctor if you have history of pancreatitis.

Insulin and sulfonylureas (increased hypoglycaemia risk), digoxin (may increase digoxin levels—monitor), strong P-gp inhibitors may affect levels (clinical relevance usually low).

Store at room temperature (below 25°C), protected from moisture and direct light. Keep in original blister pack and out of reach of children.

Januvia 25 mg Tablet, Istavel 25 mg Tablet, Zita 25 mg Tablet, Sitasmart 25 mg Tablet, Sitacom 25 mg Tablet